Anya Bershad, Md, Phd

This early-stage study is checking if MDMA (commonly known as ecstasy) is safe for people with schizophrenia. It aims to see if low doses worsen psychotic symptoms like hallucinations or delusions. The goal is to eventually use the drug's known social-bonding effects to treat sev…